Compounds > agreal
Page last updated: 2024-08-23

agreal and Osteoporosis, Postmenopausal

agreal has been researched along with Osteoporosis, Postmenopausal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cianci, A; De Leo, V; Farina, M; La Marca, A; Morgante, G; Petraglia, F1
Alonso-Coello, P; Marzo-Castillejo, M1

Trials

1 trial(s) available for agreal and Osteoporosis, Postmenopausal

ArticleYear
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:4

    Topics: Bone Density; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Female; Hot Flashes; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prolactin; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sulpiride; Treatment Outcome

2004

Other Studies

1 other study(ies) available for agreal and Osteoporosis, Postmenopausal

ArticleYear
[Clinical guide to the menopause and post-menopause].
    Atencion primaria, 2005, Sep-30, Volume: 36, Issue:5

    Topics: Aged; Female; Fractures, Bone; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Practice Guidelines as Topic; Primary Health Care; Spain; Sulpiride

2005